Boeding Chad

CIK 00017794513 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001779451

Recent Transactions

46 trades

Other
Applied Molecular Transport Inc.
Common Stock
2023-12-27−3,394,948→ 2,793,278 total
Other
Applied Molecular Transport Inc.
Common Stock
2023-12-27−2,149,292→ 6,188,226 total
Other
Applied Molecular Transport Inc.
Common Stock
2023-12-27−293,278→ 0 total
Other
Applied Molecular Transport Inc.
Common Stock
2023-12-27−2,500,000→ 293,278 total
Other
Lucira Health, Inc.
Common Stock
2022-12-14−3,754,084→ 5,940,677 total
Other
Lucira Health, Inc.
Common Stock
2022-12-14−5,173,026→ 767,651 total
Other
Lucira Health, Inc.
Common Stock
2022-12-14+256,742→ 288,918 total
Other
Lucira Health, Inc.
Common Stock
2022-12-14+725,675→ 1,014,593 total
Other
Lucira Health, Inc.
Common Stock
2022-12-14−3,461,764→ 9,694,761 total
Other
Lucira Health, Inc.
Common Stock
2022-12-14−735,475→ 32,176 total
Purchase
Applied Molecular Transport Inc.
Common Stock
2022-05-13$4.17/sh+29,763→ 8,337,518 total
Purchase
Applied Molecular Transport Inc.
Common Stock
2022-05-12$3.88/sh+32,380→ 8,307,755 total
Conversion
Lucira Health, Inc.
Series B Convertible Preferred
2021-02-05−32,176→ 0 total
Conversion
Lucira Health, Inc.
Series C Convertible Preferred
2021-02-05−5,173,026→ 0 total
Purchase
Lucira Health, Inc.
Common Stock
2021-02-05$17.00/sh+3,461,764→ 3,461,764 total
Conversion
Lucira Health, Inc.
Series B Convertible Preferred
2021-02-05−3,754,084→ 0 total
Conversion
Lucira Health, Inc.
Common Stock
2021-02-05+5,173,026→ 5,173,026 total
Conversion
Lucira Health, Inc.
Common Stock
2021-02-05+3,754,084→ 3,754,084 total
Conversion
Lucira Health, Inc.
2020B Convertible Promissory Note
2021-02-05$17.00/sh−735,475→ 0 total
Conversion
Lucira Health, Inc.
Common Stock
2021-02-05+32,176→ 32,176 total
Conversion
Lucira Health, Inc.
Common Stock
2021-02-05$17.00/sh+735,475→ 735,475 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-06-12$44.06/sh+2,440→ 2,860,967 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-06-11$44.32/sh+6,600→ 2,858,527 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-05-22$55.90/sh+2,085→ 2,851,927 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-05-21$55.80/sh+520→ 2,849,842 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-05-20$57.22/sh+417→ 2,849,322 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-05-20$58.00/sh+5,668→ 2,848,905 total
Other
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-01-29$54.30/sh−4,338→ 2,843,237 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2019-08-21$24.87/sh+1,635→ 2,847,575 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2019-08-21$24.87/sh+420→ 2,845,940 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2019-08-21$24.87/sh+1,635→ 2,834,561 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2019-08-21$24.87/sh+420→ 2,832,926 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2019-08-20$25.69/sh+600→ 2,843,210 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2019-08-20$25.69/sh+600→ 2,830,196 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2019-08-20$25.69/sh+2,310→ 2,845,520 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2019-08-20$25.69/sh+2,310→ 2,832,506 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2019-08-19$26.50/sh+2,100→ 2,842,610 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2019-08-19$26.50/sh+2,100→ 2,829,596 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2019-08-16$26.37/sh+700→ 2,827,496 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2019-08-16$26.37/sh+700→ 2,840,510 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2019-05-10$27.58/sh+4,170→ 2,839,730 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2019-05-10$26.41/sh+4,350→ 2,822,546 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2019-05-10$27.58/sh+4,170→ 2,826,716 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2019-05-10$27.05/sh+80→ 2,839,810 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2019-05-10$27.05/sh+80→ 2,826,796 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2019-05-10$26.41/sh+4,350→ 2,835,560 total

Companies

Recent Filings

Address

ONE LOMBARD STREET, SUITE 200

SAN FRANCISCO, CA, 94111

View on SEC.gov